W
William Oh
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 915
Citations - 53207
William Oh is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 100, co-authored 867 publications receiving 48760 citations. Previous affiliations of William Oh include University of British Columbia & Stanford University.
Papers
More filters
Journal ArticleDOI
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.
Seetha Shankaran,Abbot R. Laptook,Richard A. Ehrenkranz,Jon E. Tyson,Scott A. McDonald,Edward F. Donovan,Avroy A. Fanaroff,W. Kenneth Poole,Linda L. Wright,Rosemary D. Higgins,Neil N. Finer,Waldemar A. Carlo,Shahnaz Duara,William Oh,C. Michael Cotten,David K. Stevenson,Barbara J. Stoll,James A. Lemons,Ronnie Guillet,Alan H. Jobe +19 more
TL;DR: Whole-body hypothermia reduces the risk of death or disability in infants with moderate or severe hypoxic–ischemic encephalopathy and there was no increase in major disability among survivors.
Journal ArticleDOI
Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
Barbara J. Stoll,Nellie I. Hansen,Avroy A. Fanaroff,Linda L. Wright,Waldemar A. Carlo,Richard A. Ehrenkranz,James A. Lemons,Edward F. Donovan,Ann R. Stark,Jon E. Tyson,William Oh,Charles R. Bauer,Sheldon B. Korones,Seetha Shankaran,Abbot R. Laptook,David K. Stevenson,Lu Ann Papile,W. Kenneth Poole +17 more
TL;DR: Infants who developed late-onset sepsis had a significantly prolonged hospital stay and were significantly more likely to die than those who were uninfected, especially if they were infected with Gram-negative organisms or fungi.
Journal ArticleDOI
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
Daniel Y.C. Heng,Wanling Xie,Meredith M. Regan,Mark Andrew Warren,Ali Reza Golshayan,Chakshu Sahi,Bernhard J. Eigl,J. Dean Ruether,Tina Cheng,Scott North,Peter Venner,Jennifer J. Knox,Kim N. Chi,Christian Kollmannsberger,David F. McDermott,William Oh,Michael B. Atkins,Ronald M. Bukowski,Brian I. Rini,Toni K. Choueiri +19 more
TL;DR: This model validates components of the MSKCC model with the addition of platelet and neutrophil counts and can be incorporated into patient care and into clinical trials that use VEGF-targeted agents.
Journal ArticleDOI
Trends in neonatal morbidity and mortality for very low birthweight infants
Avroy A. Fanaroff,Barbara J. Stoll,Linda L. Wright,Waldemar A. Carlo,Richard A. Ehrenkranz,Ann R. Stark,Charles R. Bauer,Edward F. Donovan,Sheldon B. Korones,Abbot R. Laptook,James A. Lemons,William Oh,Lu Ann Papile,Seetha Shankaran,David K. Stevenson,Jon E. Tyson,W. Kenneth Poole +16 more
TL;DR: There have been no significant increases in survival without neonatal and long-term morbidity among VLBW infants between 1997 and 2002, and it is speculated that to improve survival without morbidity requires determining, disseminating, and applying best practices using therapies currently available, and also identifying new strategies and interventions.
Journal ArticleDOI
Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes
Larry C. Gilstrap,Robert Christensen,William H. Clewell,Mary E. D'Alton,Ezra C. Davidson,Marilyn B. Escobedo,Dwenda K. Gjerdingen,Jan Goddard-Finegold,Robert L. Goldenberg,David A. Grimes,Thomas N. Hansen,Ralph E. Kauffman,Emmett B. Keeler,William Oh,Elizabeth J. Susman,Marlyn G. Vogel,Mary Ellen Avery,Philip L. Ballard,Roberta A. Ballard,Patricia Crowley,Thomas J. Garite,Gary D.V. Hankins,Alan H. Jobe,Janna G. Koppe,James Maher,Irwin R. Merkatz,Seetha Shankaran,Kit N. Simpson,John C. Sinclair,Theodore A. Slotkin,H. William Taeusch,Linda L. Wright,Duane F. Alexander,Mary Anne Berberich,Michael B. Bracken,Leslie T. Cooper,Larry Culpepper,Jerry M. Elliott,John H. Ferguson,Frederic Frigoletto,Dorothy Berlin Gail,William H. Hall,M. Douglas Jones,Barbara Medoff-Cooper,Gerald B. Merenstein,Judith M. Whalen,Claude Lenfant,Ada Sue Hinshaw +47 more
TL;DR: Antenatal corticosteroid therapy is indicated for women at risk of premature delivery with few exceptions and will result in a substantial decrease in neonatal morbidity and mortality, as well as substantial savings in health care costs.